Relationship between vascular endothelial growth factors and advanced glycation end products in the human vitreous

Journal of Japanese Ophthalmological Society

Volumn 102, Issue 7, 1998, Pages 442-446

  Hashimoto, Hirotaka ^a   Arai, Kiyomi ^a   Chikuda, Makoto ^a   Obara, Yoshitaka ^b  

^a DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Dokkyo University School of Medicine

Author keywords

Diabetic retinopathy; Glycation; Pentosidine; Vascular endothelial growth factors (VEGF)

Indexed keywords

CYCLIC AMP; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; PENTOSIDINE; PROTEIN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE RELEASE; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE COURSE; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; VITREOUS BODY;

ADULT; ARGININE; CYTOKINES; DIABETIC RETINOPATHY; DISEASE PROGRESSION; ENDOTHELIAL GROWTH FACTORS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LYMPHOKINES; LYSINE; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VITREOUS BODY;

EID: 0031844158     PISSN: 00290203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al : Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331 : 1480-1487, 1994.
2. Adamis AP, Miller JW, Bernal MT, D' Amico DJ, Folkman J, Yeo TK, et al : Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118 : 445-450, 1994.
3. Yamamoto Y, Yamagishi S, Hsu CC. Yamamoto H : Advanced glycation end products-receptor interactions stimulate the growth of human pancreatic cancer cells through the induction of platelet - derived growth factor-B. Biochem Biophys Res Commun 222 . 700-705, 1996.
4. Hirata C, Nakano K, Nakamura N, Kitagawa Y, Shigeta H, Hasegawa G, et al : Advanced glycation end products induce expression of vascular endothelial growth factor by retinal müller cells. Biochem Biophys Res Commun 236 : 712-715, 1997.
5. Takahashi M, Kushida K, Kawana K, Ishihara C, Denda M, InoueT, et al : Quantification of cross link pentosidine in serum from normal and uremic subjects. Clin Chem 39 : 2162-2165, 1993.
6. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak JF : Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219 : 983-985, 1983.
7. Leung DR, Cachianes G, Kuang W-J, Goeddel DV, Ferrara N : Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246 : 1306-1309. 1989.
8. Sell DR, Monnier VM : Structure elucidation of a senescence cross-link from human extracellular matrix. J Biol Chem 264 : 21597-21602, 1989.
9. Vlassara H, Brownlee M, Cerami A : High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins : A potential mechanism for the removal of senescent macromolecules. Proc Natl Acad Sci USA 82 : 5588-5592, 1985.
10. Tezuka M, Koyama N, Morisaki N, Saito Y, Yoshida S, Araki N, et al: Angiogenic effects of advanced glycation end products of the Maillard reaction on cultured human unbilical cord vein endothelial cells. Biochem Biophys Res Commun 193 : 674-680, 1993.
11. Monnier VM, Sell DR, Nagaraj RH, Miyata S, Grandhee S, Odetti P, et al : Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes 41 : 36-41, 1992.
12. Dyer DG, Dunn JA, Thorpe SR, Bailie KE, Lyons TJ, McCance DR, et al : Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 91 : 2463-2469, 1993.